UK markets closed
NIKKEI 225
38,236.07 -38.03 (-0.10%) HANG SENG
18,455.86 -20.06 (-0.11%) CRUDE OIL
78.42 +0.31 (+0.40%) GOLD FUTURES
2,322.70 +14.10 (+0.61%) DOW
38,675.68 +449.98 (+1.18%) Bitcoin GBP
51,074.36 +551.39 (+1.09%)
NeoGenomics, Inc. (NEO)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous close | 14.72 |
| Open | 15.07 |
| Bid | 15.28 x 400 |
| Ask | 15.34 x 400 |
| Day's range | 14.90 - 15.39 |
| 52-week range | 11.03 - 21.22 |
| Volume | |
| Avg. volume | 963,545 |
| Market cap | 1.954B |
| Beta (5Y monthly) | 1.10 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.66 |
| Earnings date | 30 Apr 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 20.45 |
Insider MonkeyNeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript April 30, 2024 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03. NEO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the NeoGenomics First Quarter 2024 Financial […]
Simply Wall St.NeoGenomics First Quarter 2024 Earnings: Revenues Beat Expectations, EPS Lags
NeoGenomics ( NASDAQ:NEO ) First Quarter 2024 Results Key Financial Results Revenue: US$156.2m (up 14% from 1Q 2023...
- GuruFocus.com
NeoGenomics Inc (NEO) Q1 2024 Earnings Call Transcript Highlights: Strategic Growth and ...
Discover how NeoGenomics is navigating market dynamics with robust revenue growth and strategic expansions in clinical diagnostics.
© 2024 Yahoo. All rights reserved.